CMG vs SNDX · P/E 50, rev $3.35B vs rev $137.7M
Chipotle Mexican Grill Inc (CMG) versus Syndax Pharmaceuticals Inc (SNDX) — a side-by-side from cached financials, not a winner call.
Chipotle Mexican Grill Inc (CMG) is a restaurants company listed on US.
Syndax Pharmaceuticals Inc (SNDX) is a biotechnology company listed on US.
Latest reported CMG revenue for 2026-06-30 was $3.35B. Net income was $403.5M. Revenue was up 8.4% from 2026-03-31 to 2026-06-30. CMG currently screens at market cap $76.00B and trailing P/E 50.0.
Latest reported SNDX revenue for 2026-06-30 was $137.7M. Net income was -$92.0M. SNDX currently screens at market cap $774.4M.
CMG currently screens at market cap $76.00B and trailing P/E 50.0. SNDX currently screens at market cap $774.4M.
Not investment advice. Open the CMG and SNDX stock pages for the full models.
Not investment advice.